These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2278306)

  • 1. [Secondary immunodeficiency and its correction with thymus preparations in patients with postabortion endometritis].
    Franchuk AE; Benzar ZT
    Akush Ginekol (Mosk); 1990 Sep; (9):40-3. PubMed ID: 2278306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
    Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
    Sov Med; 1990; (6):111-3. PubMed ID: 2144365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
    Iakhontova OI; Dudanova OP; Khavinson VKh
    Sov Med; 1990; (6):85-8. PubMed ID: 2396134
    [No Abstract]   [Full Text] [Related]  

  • 5. [Principles of immunocorrective therapy using the thymus preparation T-activin].
    Arion VIa; Ivanushkin EF
    Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
    [No Abstract]   [Full Text] [Related]  

  • 6. [The efficacy of immunomodulating preparations in treating patients with chronic cholestatic liver diseases].
    Radchenko VG; Mitrofanova TI; Serebriakova VI; Vinogradova GL
    Lik Sprava; 1992; (11-12):38-41. PubMed ID: 1292217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A cytomorphological basis for the correction of radiation-induced immunodeficiencies and hematopoietic depression using thymus and bone marrow peptides].
    Khmel'nitskiĭ OK; Grintsevich II; Kotov VA; Seryĭ SV
    Arkh Patol; 1993; 55(2):50-3. PubMed ID: 7980063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of taktivin in experimental apical periodontitis exacerbated by a secondary immunodeficiency state].
    Zyrianov GV; Dmitrieva LA; Frolova TM; Belopol'skiĭ AA; Babaian SS
    Stomatologiia (Mosk); 1993; 72(2):10-3. PubMed ID: 8048117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the immune system in the pathogenesis and treatment of suppurative-inflammatory diseases after cesarean section].
    Timoshenko LV; Vdovichenko IuP
    Akush Ginekol (Mosk); 1990 Nov; (11):9-12. PubMed ID: 2077924
    [No Abstract]   [Full Text] [Related]  

  • 11. [The electrophoretic mobility of peripheral blood lymphocytes in patients with tuberculosis of the lungs].
    Skvortsova RG; Nikitina OI
    Probl Tuberk; 1990; (5):11-4. PubMed ID: 2388887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune reactivity of patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Mel'nik VP
    Vrach Delo; 1989 Apr; (4):82-5. PubMed ID: 2787943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of thymus preparations and anti-tuberculosis agents on immunologic reactivity and the course of the tuberculosis process in experimental animals].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Probl Tuberk; 1991; (12):52-4. PubMed ID: 1803376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 15. [The validation of the use of thymic preparations in tuberculous infection by experimental data].
    Demidov SV; Miasnikov VG; Chernushenko EF; Osipova LS
    Vrach Delo; 1991 May; (5):53-5. PubMed ID: 1866916
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of T-activin for the prevention of congenital influenzal infection in mice and the correction of the immune deficiency].
    Mirchink EP; Pronin AV; Arion VIa; Deeva AV; Zimina IV; Zuev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Apr; (4):60-4. PubMed ID: 2385991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapy in the combined treatment of chronic destructive pulmonary tuberculosis].
    Ivanova LA
    Probl Tuberk; 1994; (3):16-9. PubMed ID: 7937662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of an experimental tuberculous process in the presence of immune deficiency and immunostimulation].
    Shcherbakova NM; Aleksandrova AE; Morozov VG; Podosinnikov IS; Khavinson VKh
    Biull Eksp Biol Med; 1981 Sep; 92(9):320-2. PubMed ID: 6895337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
    Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
    Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correction with T-activin of secondary immunodeficiency in inflammatory diseases of female internal genital organs].
    Pogodin OK; Samorodinova LA; Matveeva NK; Sukhikh GT
    Akush Ginekol (Mosk); 1991 Apr; (4):40-4. PubMed ID: 1862873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.